“Lebrikizumab Patients Treated in the Real World: First North American Data from the PPDTM CorEvitasTM AD Registry”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s609, https://doi.org/10.25251/gmn1ta26.